Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06353594
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2024-03-14
Brief Title:
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI
Sponsor:
Jorge Sanz Sanchez
Organization:
Hospital Universitario La Fe
Study Overview
Official Title:
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With St-segment Elevation Myocardial Infarction Copernican
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COPERNICAN
Brief Summary:
The objective is to compare a reduced stent strategy based on drug-coated balloon DCB percutaneous coronary intervention PCI with conventional drug-eluting stent DES coronary revascularization in patients presenting with ST-segment myocardial infarction STEMI
Randomization will be performed after successful culprit-lesion guidewire crossing and flow restoration Random allocation in a 11 fashion to one of the following strategies
Study group reduced stent PCI strategy DCB-based
Control group conventional PCI strategy DES-based
Randomization will be performed after successful culprit-lesion guidewire crossing and flow restoration Random allocation in a 11 fashion to one of the following strategies
Study group reduced stent PCI strategy DCB-based
Control group conventional PCI strategy DES-based
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None